Article
JAK Inhibition Differentially Affects NK Cell and ILC1 Homeostasis
19 Dec 2019
Abstract excerpt
Janus kinase (JAK) inhibitors are widely used in the treatment of multiple autoimmune and inflammatory diseases. Immunologic and transcriptomic profiling have revealed major alterations on natural killer (NK) cell homeostasis associated with JAK inhibitions, while information on other innate lymphoid cells (ILCs) is still lacking. Herein, we observed that, in mice, the homeostatic pool of liver ILC1 was less...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
